Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Expert urges national stay-at-home order as India's COVID cases near 20 million

Published 2021-05-03, 01:03 a/m
© Reuters. A doctor checks an X-ray of a patient suffering from the coronavirus disease (COVID-19) inside a COVID-19 ward of a hospital in New Delhi

By Tanvi Mehta and Shilpa Jamkhandikar

NEW DELHI/MUMBAI (Reuters) - India reported more than 300,000 new coronavirus infections for a 12th straight day on Monday to take its overall number of cases to just shy of 20 million, as scientists predicted a peak in the pandemic in the coming days.

With 368,147 new cases over the past 24 hours, India's total infections stand at 19.93 million, while total fatalities rose by 3,417 to 218,959, according to health ministry data.

Medical experts say actual numbers across the country of 1.35 billion may be five to 10 times higher than the official tally.

The health ministry offered a glimmer of hope, reporting that positive cases relative to the number of tests conducted fell on Monday for the first time since at least April 15.

(For graphic on India's daily positivity rate - https://graphics.reuters.com/HEALTH-CORONAVIRUS/INDIA/gjnvwdqlrpw/chart.png)

India's coronavirus cases may peak between May 3-5, according to a mathematical model from a team of scientists advising the government, a few days earlier than a previous estimate as the virus has spread faster than expected.

Hospitals have filled to capacity, medical oxygen supplies have run short and morgues and crematoriums have been swamped as the country deals with the surge in cases.

At least 11 states and union territories have imposed some form of restrictions on movement to try and stem infections, but Prime Minister Narendra Modi's government is reluctant to announce a national lockdown, concerned about the economic impact.

"In my opinion, only a national stay at home order and declaring medical emergency will help to address the current healthcare needs," Bhramar Mukherjee, an epidemiologist with the University of Michigan said on Twitter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The # of active cases is accumulating, not just the daily new cases. Even the reported numbers state there are around 3.5M active cases."

CRISIS TESTS MODI

The spike in infections is India's biggest crisis since Modi took office in 2014. Modi has been criticised for not taking steps earlier to curb the spread and for letting millions of largely unmasked people attend religious festivals and crowded political rallies in five states during March and April.

A forum of scientific advisers set up by the government warned Indian officials in early March of a new and more contagious variant of the coronavirus taking hold in the country, five scientists who are part of the forum told Reuters.

Despite the warning, four of the scientists said the federal government did not seek to impose major restrictions to stop the spread of the virus.

It remains to be seen how his handling of the crisis might affect Modi or his party politically. The next general election is due in 2024. Modi's party was defeated in India's West Bengal state in results declared on Sunday, although it won in the neighbouring state of Assam.

Leaders of 13 opposition parties signed a letter on Sunday urging Modi to immediately launch free national vaccination and to prioritise oxygen supply to hospitals and health centres.

Several states have postponed widening a vaccination drive for adults that was to start on Saturday due to a lack of vaccines. Despite being the world's biggest producer of vaccines, India does not have enough for itself. Only about 9% of the population has had a dose.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

India has struggled to increase capacity beyond 80 million doses a month due to lack of raw materials and a fire at the Serum Institute, which makes the AstraZeneca (NASDAQ:AZN) vaccine.

Pfizer Inc (NYSE:PFE) is in talks with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

India said last month its drugs regulator will decide on emergency-use applications for foreign COVID-19 vaccines, including Pfizer, within three working days from application.

International aid has been pouring into India in response to the crisis.

Britain will send another 1,000 ventilators to India, the government said on Sunday. Prime ministers Boris Johnson and Modi are scheduled to talk on Tuesday.

The Indian COVID-19 variant has now reached at least 17 countries including Britain, Switzerland and Iran, leading several governments to close their borders to people travelling from India.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.